Speaking from the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Michael Atkins, MD, of Georgetown University, Washington, DC, tells us about the potential benefits of combining immunotherapy drugs with VEGF inhibitors such as axitinib in patients with renal cancer.
Combining immunotherapy with VEGF inhibitors to treat kidney cancer
